BioSpace News Archive

Press Releases

Vivacelle Bio Initiates Phase 3 Trial for Lead Asset VBI-S to Treat Patients with Hypovolemia Due to Septic Shock

July 23, 2024
·
5 min read
Press Releases

BIOVAXYS ANNOUNCES ISSUANCE OF DPX RELATED PATENT FROM THE U.S. PATENT AND TRADEMARK OFFICE

July 23, 2024
·
6 min read
Press Releases

Alcanza Clinical Research Joins SCRS Global Impact Partner Program

July 23, 2024
·
2 min read
Press Releases

Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement

July 23, 2024
·
8 min read
Press Releases

Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound Gel

July 23, 2024
·
2 min read
Press Releases

Virios Therapeutics Announces Completion of Enrollment in IMC-2 Phase 2 Long-COVID Study Being Conducted by Bateman Horne Center

July 23, 2024
·
4 min read
Press Releases

Voydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults with the rare disease PNH who have residual hemolytic anemia due to extravascular hemolysis

July 23, 2024
·
9 min read
Press Releases

FDA Accepts Mesoblast’s Biologics License Application (BLA) for Ryoncil® in Children With Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)

July 23, 2024
·
10 min read
Press Releases

Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024

July 23, 2024
·
17 min read
Business

Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024

July 23, 2024
·
1 min read